Login / Signup

Is the "P-value" Alone a Sufficient Metric for the Magnitude of Clinical Benefit and Which Clinical Trial Is Actually Positive, KEYNOTE-394 or KEYNOTE-240?

Tülay KuşGokmen AktasIrfan Cicin
Published in: The oncologist (2023)
Keyphrases
  • phase ii
  • clinical trial
  • open label
  • double blind
  • phase iii